Even for companies with massive R&D output, targeted deals with SEP-focused research labs seem to fit a strategic need
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Asia-Pacific editor
@IAM_Alerts RT @IAM_Alerts: The Biden Administration’s decision to support a suspension of covid vaccine IP rights raises powerful concerns that go way… Read more
@IAM_Alerts The Biden Administration’s decision to support a suspension of covid vaccine IP rights raises powerful concerns tha… https://t.co/g1cNDjVQyc Read more
@IAM_Alerts A deep dive into LG's smartphone patent holdings shows that they are likely to be of significant interest to a larg… https://t.co/Dw6Zk3Uk46 Read more
@IAM_Alerts Many expected this, but perhaps not so soon ...
https://t.co/vGLoaqHm7E Read more